Literature DB >> 4352316

Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.

E Engelsman, J P Persijn, C B Korsten, F J Cleton.   

Abstract

Oestrogen receptor determinations were done in metastatic breast cancer tissue of patients with advanced breast cancer. In 37 patients with progressive disease evaluation of the response to endocrine treatment was possible, following the criteria of the E.O.R.T.C. Co-operative Breast Cancer Group. In 20 patients with receptor-negative tumours two objective remissions were noted; in 17 patients with receptor-positive tumours 14 objective remissions were seen. There seems to be a striking correlation between the presence or absence of oestrogen receptor in tumour tissue and the clinical response to hormonal therapy.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352316      PMCID: PMC1589773          DOI: 10.1136/bmj.2.5869.750

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  THE UPTAKE OF (6,7-3-H)OESTRADIOL BY DIMETHYLBENZANTHRACENE-INDUCED RAT MAMMARY TUMOURS.

Authors:  R J KING; D M COWAN; D R INMAN
Journal:  J Endocrinol       Date:  1965-04       Impact factor: 4.286

2.  Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy.

Authors:  P J FOLCA; R F GLASCOCK; W T IRVINE
Journal:  Lancet       Date:  1961-10-07       Impact factor: 79.321

3.  Estrogen receptors in human breast cancer tissue.

Authors:  H Maass; B Engel; H Hohmeister; F Lehmann; G Trams
Journal:  Am J Obstet Gynecol       Date:  1972-06-01       Impact factor: 8.661

4.  Prognostic significance of oestrogen uptake by human breast-cancer tissue.

Authors:  H Braunsberg; V H James; W T Irvine; C W Jamieson; F James; R A Sellwood; A E Carter; M Hulbert
Journal:  Lancet       Date:  1973-01-27       Impact factor: 79.321

5.  The intranuclear localization of [6,7-3H]-oestradiol-17-beta in dimethylbenzanthracene-induced rat mammary adenocarcinoma and other tissues.

Authors:  R J King; J Gordon; D M Cowan; D R Inman
Journal:  J Endocrinol       Date:  1966-10       Impact factor: 4.286

  5 in total
  8 in total

1.  Oestrogen receptors in breast cancer: a changing concept.

Authors:  G Leclercq; J C Heuson; M C Deboel; W H Mattheiem
Journal:  Br Med J       Date:  1975-01-25

2.  Estrogen receptors in breast cancer.

Authors:  E V Jensen; G E Block; D J Ferguson; E R DeSombre
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

3.  Letter: Breast cancer regression under oestrogen therapy.

Authors:  P Garcia Webb; M H Briggs
Journal:  Br Med J       Date:  1973-11-17

4.  Letter: Breast cancer regression under oestrogen therapy.

Authors:  M L'Hermite; C Robyn; J C Heuson; M Rozencweig
Journal:  Br Med J       Date:  1974-03-02

5.  [Histological diagnosis, DNA-content and chromatin pattern of breast cancer cases with positive and negative 17-beta-oestradiol receptor binding (author's transl)].

Authors:  H Sachs; J Winzer
Journal:  Arch Gynakol       Date:  1976-12-10

6.  Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography.

Authors:  D Millington; D A Jenner; T Jones; K Griffiths
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

7.  Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases.

Authors:  H J Bloom; E Boesen
Journal:  Br Med J       Date:  1974-04-06

8.  High affinity oestradiol receptors and the activity of glucose-6-phosphate dehydrogenase and lactose synthetase in mammary carcinomata of postmenopausal women.

Authors:  J L Daehnfeldt; M Schülein
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.